• Valuation of patents for a listed biotechnology company
  • Valuation of an operator of rehabilitation clinics in the context of claims for damages
  • Valuation of a home care company in the context of a sale of shares to co-partners
  • Valuation of a home health care company in the context of a shareholder withdrawal
  • Valuation of a medical technology company in the context of claims for damages
  • Valuation of a company in the field of “clinical trials” (CRO) in the context of post-M&A claims for damages